Get started
Author

Zhanxiong Luo

Observed names: Luo, Zhan-xiong, Zhan-xiong Luo
ORCID: 0000-0002-3741-4691
Observed ORCID: 0000-0002-3741-4691
OpenAlex ID: A5100675952
Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN-1st): a multicentre, randomised, double-blind, phase 3 trial
2021 · Yunpeng Yang, Song Qu, et al. · The Lancet Oncology · 494
First-Line Sugemalimab Plus Chemotherapy for Advanced Gastric Cancer: The GEMSTONE-303 Randomized Clinical Trial
2025 · Xiaotian Zhang, Jufeng Wang, et al. · JAMA · 92
Administration of nimotuzumab combined with cisplatin plus 5-fluorouracil as induction therapy improves treatment response and tolerance in patients with locally advanced nasopharyngeal carcinoma receiving concurrent radiochemotherapy: a multicenter randomized controlled study
2019 · Ying Lu, Dagui Chen, et al. · BMC Cancer · 31
PDF
LINC00511/hsa-miR-573 axis-mediated high expression of Gasdermin C associates with dismal prognosis and tumor immune infiltration of breast cancer
2022 · Kai Sun, Ri-xin Chen, et al. · Scientific Reports · 30
PDF
Finotonlimab (PD-1 inhibitor) plus bevacizumab (bevacizumab biosimilar) as first-tier therapy for late-stage hepatocellular carcinoma: a randomized phase 2/3 trial
2025 · Chuanhua Zhao, Yanqiao Zhang, et al. · Signal Transduction and Targeted Therapy · 27
PDF
The Ratio of CD86+/CD163+ Macrophages Predicts Postoperative Recurrence in Stage II-III Colorectal Cancer
2021 · Guozeng Xu, Lei Jiang, et al. · Frontiers in Immunology · 19
PDF
Five-Year Outcome of Camrelizumab Plus Chemotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma: A Secondary Analysis of the CAPTAIN-1st Randomized Clinical Trial
2026 · Yan Huang, Dongchen Sun, et al. · JAMA Oncology · 15
Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification
2022 · Kai Sun, Cheng Huang, et al. · World Journal of Surgical Oncology · 15
PDF
A single-arm, multicenter, phase 2 clinical study of recombinant humanized anti-HER2 monoclonal antibody-MMAE conjugate (MRG002) in HER2-positive unresectable locally advanced or metastatic urothelial carcinoma
2024 · Wang Qu, Cheng Fu, et al. · European Journal of Cancer · 12
Identification and validation of necroptosis-related prognostic gene signature and tumor immune microenvironment infiltration characterization in esophageal carcinoma
2022 · Kai Sun, Juan-juan Hong, et al. · BMC Gastroenterology · 12
PDF
Camrelizumab versus placebo combined with gemcitabine and cisplatin for recurrent or metastatic nasopharyngeal carcinoma: A randomized, double-blind, phase 3 trial.
2021 · Li Zhang, Yunpeng Yang, et al. · Journal of Clinical Oncology · 8
LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma
2022 · Kai Sun, Ri-xin Chen, et al. · Hereditas · 6
PDF
Prognostic value of neutrophil to lymphocyte ratio in patients with nasopharyngeal carcinoma: A meta-analysis
2017 · Bin Yu, Zhonghua Li, et al. · Biomedical Research-tokyo · 4
Preparation of NiMoO4/CdS and its Application as a Photocatalyst in H2 Evolution Reaction
2023 · Qiuyan Fu, Lijing Zhang, et al. · ChemistrySelect · 2
PDF
A phase 2/3 study of romiplostim N01 in chemotherapy-induced thrombocytopenia (CIT).
2024 · Xiaoxiao Ge, Qingyuan Zhang, et al. · JCO Oncology Practice · 1
PDF
Role of Cinobu facini injection combines with supportive care for advanced hepatoma
2009 · Zhanxiong Luo · Internal Medicine of China · 1
Efficacy of Endostar plus concurrent chemoradiotherapy in locally advanced cervical cancer: a multicenter, phase II randomized trial
2025 · Fang Wu, Xiaobi Tang, et al. · Therapeutic Advances in Medical Oncology
Additional file 4 of Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification
2022 · Sun, Kai, Huang, Cheng, et al. · Figshare
Additional file 2 of LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma
2022 · Sun, Kai, Chen, Ri-xin, et al. · Figshare
Additional file 2 of Identification and validation of necroptosis-related prognostic gene signature and tumor immune microenvironment infiltration characterization in esophageal carcinoma
2022 · Sun, Kai, Hong, Juan-juan, et al. · Figshare
Additional file 3 of Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification
2022 · Sun, Kai, Huang, Cheng, et al. · Figshare
Additional file 1 of Identification and validation of necroptosis-related prognostic gene signature and tumor immune microenvironment infiltration characterization in esophageal carcinoma
2022 · Sun, Kai, Hong, Juan-juan, et al. · Figshare
Additional file 3 of LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma
2022 · Sun, Kai, Chen, Ri-xin, et al. · Figshare
Additional file 2 of Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification
2022 · Sun, Kai, Huang, Cheng, et al. · Figshare
Expressions and Prognostic values of LPARs in human breast cancer
2021 · Tao Wang, Zhanxiong Luo, et al. · Research Square
PDF
Works count: 28
Citation count: 769
H-index: 10
I10-index: 10
Year
Topic
Type